Vulvar Lichen Sclerosus clinical trials

Explore recruiting vulvar lichen sclerosus clinical trials.

Recruiting vulvar lichen sclerosus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vulvar Lichen Sclerosus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A parallel group (2-arm), randomised, double-blind, 12-week trial to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women diagnosed with vulvar lichen sclerosus (VLS)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Vulvar Lichen Sclerosus trials by city

Vulvar Lichen Sclerosus in Toronto Vulvar Lichen Sclerosus in Vancouver Vulvar Lichen Sclerosus in Montreal Vulvar Lichen Sclerosus in Calgary Vulvar Lichen Sclerosus in Edmonton Vulvar Lichen Sclerosus in Ottawa Vulvar Lichen Sclerosus in Winnipeg Vulvar Lichen Sclerosus in Quebec City Vulvar Lichen Sclerosus in Hamilton Vulvar Lichen Sclerosus in Kitchener Vulvar Lichen Sclerosus in London Vulvar Lichen Sclerosus in Halifax Vulvar Lichen Sclerosus in New York Vulvar Lichen Sclerosus in Los Angeles Vulvar Lichen Sclerosus in Chicago Vulvar Lichen Sclerosus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease